US5898891040
© Globe Newswire
08.01.2026
MMSI
LISTED
NASDAQ
Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025
News Preview
SOUTH JORDAN, Utah, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that its Board of Directors unanimously appointed F. Ann Millner, Ed.D., formerly Merit’s Lead Independent Director, as Chair of the Board effective January 5, 2026....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
MMSI
LISTED
NASDAQ
Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
News Preview
SOUTH JORDAN, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced positive findings from the randomized AVF arm of the WAVE trial. These findings were presented during the Late-Breaking Clinical Trials session on Tuesday, November 4, 2025, at the Vascular In...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
MMSI
LISTED
NASDAQ
Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
News Preview
SOUTH JORDAN, Utah, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced 24-month efficacy findings from the non-randomized AVG cohort of the WAVE trial. Results of the AVG cohort were presented during the Late-Breaking Clinical Trials session at the annual VIVA Fo...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
30.10.2025
MMSI
LISTED
NASDAQ
Merit Medical Reports Third Quarter 2025 Results and Updates Full-Year Guidance
News Preview
Highlights†...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
15.10.2025
MMSI
LISTED
NASDAQ
Merit Medical Signs Asset Purchase Agreement with PENTAX Medical to Acquire C2 CryoBalloon Technology
News Preview
SOUTH JORDAN, Utah, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has signed a definitive asset purchase agreement with Pentax of America, Inc., a subsidiary of PENTAX® Medical, Inc., to acquire the C2 CryoBalloon™ device and related technology. The closi...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
MMSI
LISTED
NASDAQ
Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025
News Preview
SOUTH JORDAN, Utah, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2025, after the close of the stock market on Thursday, October 30, 2025. Merit plans t...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
MMSI
LISTED
NASDAQ
Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology
News Preview
SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.09.2025
MMSI
LISTED
NASDAQ
Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis
News Preview
Expanded indication provides patients with knee osteoarthritis the benefits of Embosphere’s consistent, predictable, and effective clinical results. Expanded indication provides patients with knee osteoarthritis the benefits of Embosphere’s consistent, predictable, and effective clinical results....
Themefolio
Profiler
Peergroup
© Globe Newswire
18.08.2025
MMSI
LISTED
NASDAQ
First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry
News Preview
SOUTH JORDAN, Utah, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today the successful enrollment of the first patient in the WRAP North America registry....
Themefolio
Profiler
Peergroup
© Globe Newswire
07.08.2025
MMSI
LISTED
NASDAQ
Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology
News Preview
Thin-wall design with superior insertion and unique sheath-securement solution to support successful radial access procedures and may aid in reducing arterial spasm and occlusion Thin-wall design with superior insertion and unique sheath-securement solution to support successful radial access procedures and may aid in reducing arterial spasm and oc...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.07.2025
MMSI
LISTED
NASDAQ
Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
News Preview
SOUTH JORDAN, Utah, July 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2025, after the close of the stock market on Wednesday, July 30, 2025. Merit plans to hold...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.05.2025
MMSI
LISTED
NASDAQ
Merit Medical Acquires Biolife Delaware, L.L.C.
News Preview
SOUTH JORDAN, Utah, May 20, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that it has acquired Biolife Delaware, L.L.C. (“Biolife”) in a merger transaction through which Biolife has become a wholly-owned subsidiary of Merit. Biolife, which is headquartered in Sarasot...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
06.05.2025
MMSI
LISTED
NASDAQ
Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis
News Preview
SOUTH JORDAN, Utah, May 06, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that the Wrapsody Cell-Impermeable Endoprosthesis (CIE) received regulatory approval from Health Canada. With this approval, Merit intends to begin immediate commercialization of the device thr...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.05.2025
MMSI
LISTED
NASDAQ
Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial
News Preview
In the AVG cohort of the US pivotal trial, the Merit WRAPSODY Cell-Impermeable Endoprosthesis (CIE) achieved 60.2% target lesion primary patency (TLPP) at 12 months. In the AVG cohort of the US pivotal trial, the Merit WRAPSODY Cell-Impermeable Endoprosthesis (CIE) achieved 60.2% target lesion primary patency (TLPP) at 12 months....
Themefolio
Profiler
Peergroup
© Globe Newswire
24.04.2025
MMSI
LISTED
NASDAQ
Merit Medical Reports First Quarter 2025 Results and Updates Full-Year Guidance
News Preview
First Quarter Highlights†...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.04.2025
MMSI
LISTED
NASDAQ
Merit Medical Launches the Ventrax™ Delivery System
News Preview
Novel all-in-one retrograde aortic access delivery system supports streamlined treatment of ventricular tachycardia Novel all-in-one retrograde aortic access delivery system supports streamlined treatment of ventricular tachycardia...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.04.2025
MMSI
LISTED
NASDAQ
Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025
News Preview
SOUTH JORDAN, Utah, April 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended March 31, 2025, after the close of the stock market on Thursday, April 24, 2025. Merit plans to hol...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.03.2025
MMSI
LISTED
NASDAQ
Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERD
News Preview
Endoscopic anti-reflux therapy recognized as evidence-based approach to providing relief of GERD symptoms. Endoscopic anti-reflux therapy recognized as evidence-based approach to providing relief of GERD symptoms....
Themefolio
Profiler
Peergroup
© Globe Newswire
25.03.2025
MMSI
LISTED
NASDAQ
Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)
News Preview
SOUTH JORDAN, Utah, March 25, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that the six-month results from the randomized arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) trial are scheduled for publication in the April issue of Kidney International. Twelve-...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.03.2025
MMSI
LISTED
NASDAQ
Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership
News Preview
SOUTH JORDAN, Utah, March 18, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced that Chairman and Chief Executive Officer, Fred Lampropoulos, will visit the Nasdaq MarketSite in Times Square to ring the opening bell on Wednesday, March 19, 2025. The ceremony begins at 9:15 A.M...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.03.2025
MMSI
LISTED
NASDAQ
First Patient Enrolled in Merit Medical’s PREEMIE Study
News Preview
Multicenter, prospective study designed to evaluate safety and efficacy of Bloom™ Micro Occluder System for treatment of patent ductus arteriosus in premature infants Multicenter, prospective study designed to evaluate safety and efficacy of Bloom™ Micro Occluder System for treatment of patent ductus arteriosus in premature infants...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.02.2025
MMSI
LISTED
NASDAQ
Merit Medical Reports Fourth Quarter and Full Year 2024 Results and Issues Fiscal Year 2025 Guidance
News Preview
Fourth Quarter Highlights†...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.01.2025
MMSI
LISTED
NASDAQ
Merit Medical Announces Preliminary Unaudited Revenue for the Year Ended December 31, 2024 and Plans to Announce Fourth Quarter and Year End 2024 Results and Issue Fiscal Year 2025 Guidance on February 25, 2025
News Preview
* Constant currency revenue is a non-GAAP financial measure. A reconciliation of this financial measure to its most directly comparable GAAP financial measure is included under the heading “Non-GAAP Financial Measure” below....
Themefolio
Profiler
Peergroup
© Globe Newswire
20.12.2024
MMSI
LISTED
NASDAQ
Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis
News Preview
SOUTH JORDAN, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that the WRAPSODY® Cell-Impermeable Endoprosthesis has received premarket approval from the US Food and Drug Administration (FDA). With this approval, Merit can begi...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.11.2024
MMSI
LISTED
NASDAQ
Merit Medical’s WRAPSODY WAVE Trial Exceeds Performance Goals for Arteriovenous Graft (AVG) Patients
News Preview
WRAPSODY achieves 82% target lesion primary patency at six months in the single-arm cohort of the US pivotal trial WRAPSODY achieves 82% target lesion primary patency at six months in the single-arm cohort of the US pivotal trial...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.11.2024
MMSI
LISTED
NASDAQ
Merit Medical Completes Acquisition of Lead Management Portfolio from Cook Medical
News Preview
SOUTH JORDAN, Utah, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today reported that it has completed the acquisition of Cook Medical’s lead management portfolio. The purchase consideration consisted of a cash payment of approximately $210 million and the assumption of cer...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2024
MMSI
LISTED
NASDAQ
Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024
News Preview
SOUTH JORDAN, Utah, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2024, after the close of the stock market on Wednesday, October 30, 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
17.09.2024
MMSI
LISTED
NASDAQ
Merit Medical Signs Agreement to Purchase Lead Management Portfolio from Cook Medical
News Preview
SOUTH JORDAN, Utah, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced it has signed a definitive asset purchase agreement to purchase Cook Medical’s lead management portfolio for total cash consideration of approximately $210 million. Merit expects to fund the...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2024
MMSI
LISTED
NASDAQ
Merit Medical to Present at the 2024 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Congress
News Preview
SOUTH JORDAN, Utah, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that clinicians will present updates on two of its pivotal studies during scientific sessions held on September 14 at CIRSE in Lisbon, Portugal....
Themefolio
Profiler
Peergroup
© Globe Newswire
01.08.2024
MMSI
LISTED
NASDAQ
Merit Medical Reports Second Quarter 2024 Results and Raises Full-Year Guidance
News Preview
Second Quarter 2024 Highlights†...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.07.2024
MMSI
LISTED
NASDAQ
Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®
News Preview
SOUTH JORDAN, Utah, July 01, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has executed an asset purchase agreement with EndoGastric Solutions, Inc. for a total cash consideration of approximately $105 million. EndoGastric Solutions’ EsophyX® Z+ device delivers a...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.06.2024
MMSI
LISTED
NASDAQ
Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
News Preview
SOUTH JORDAN, Utah, June 18, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2024, after the close of the stock market on Thursday, August 1, 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
21.05.2024
MMSI
LISTED
NASDAQ
Merit Medical Launches basixSKY™ Inflation Device
News Preview
Versatile analog device offers fast inflation and ease of use, streamlining patient care Versatile analog device offers fast inflation and ease of use, streamlining patient care...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.05.2024
MMSI
LISTED
NASDAQ
Merit Medical Expands Embolics Portfolio with New Siege™ Vascular Plug and Bearing nsPVA Express™ Prefilled Syringe
News Preview
SOUTH JORDAN, Utah, May 14, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced US Food and Drug Administration (FDA) 510(k) clearance for its Siege Vascular Plug. Merit also announced the launch of its Bearing nsPVA Express Prefilled Syringe in the United States and Austr...
Themefolio
Profiler
Peergroup
© Newsfile
31.01.2020
MMSI
LISTED
NASDAQ
Merit Medical Class Action Reminder: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Merit Medical Systems, Inc. To Contact The Firm
News Preview
New York, New York--(Newsfile Corp. - January 31, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Merit Medical Systems, Inc. (NASDAQ: MMSI) ("Merit Medical" or the "Company") of the February 3, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed ag...
Themefolio
Profiler
Peergroup
© Newsfile
30.01.2020
MMSI
LISTED
NASDAQ
MERIT MEDICAL SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Merit Medical Systems, Inc. To Contact The Firm
News Preview
New York, New York--(Newsfile Corp. - January 30, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Merit Medical Systems, Inc. (NASDAQ: MMSI) ("Merit Medical" or the "Company") of the February 3, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed a...
Themefolio
Profiler
Peergroup
© Newsfile
23.01.2020
MMSI
LISTED
NASDAQ
MERIT MEDICAL SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Merit Medical Systems, Inc. To Contact The Firm
News Preview
New York, New York--(Newsfile Corp. - January 23, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Merit Medical Systems, Inc. ("Merit Medical" or the "Company") (NASDAQ: MMSI) of the February 3, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed a...
Themefolio
Profiler
Peergroup
© Newsfile
17.01.2020
MMSI
LISTED
NASDAQ
Merit Medical Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Merit Medical Systems, Inc. To Contact The Firm
News Preview
New York, New York--(Newsfile Corp. - January 17, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Merit Medical Systems, Inc. (NASDAQ: MMSI) ("Merit Medical" or the "Company") of the February 3, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed ag...
Themefolio
Profiler
Peergroup
© Newsfile
16.01.2020
MMSI
LISTED
NASDAQ
Merit Medical Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Merit Medical Systems, Inc. To Contact The Firm
News Preview
New York, New York--(Newsfile Corp. - January 16, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Merit Medical Systems, Inc. (NASDAQ: MMSI) ("Merit Medical" or the "Company") of the February 3, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed a...
Themefolio
Profiler
Peergroup
© Newsfile
13.01.2020
MMSI
LISTED
NASDAQ
MERIT MEDICAL SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Merit Medical Systems, Inc. To Contact The Firm
News Preview
New York, New York--(Newsfile Corp. - January 13, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Merit Medical Systems, Inc. ("Merit Medical" or the "Company") (NASDAQ: MMSI) of the February 3, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed ag...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
